about
Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatmentThere's no such fool like an immunosenescent fool.Immune Thrombocytopenia in Two Unrelated Fanconi Anemia Patients - A Mere Coincidence?Editorial: Current Challenges in Immune and Other Acquired Cytopenias of ChildhoodManagement of chronic immune thrombocytopenia in children and adolescents: lessons from an Austrian national cross-sectional study of 81 patients.Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo.Fatal EBV infection and variable clinical manifestations in an XLP-1 pedigree - rapid diagnosis of primary immunodeficiencies may save lives.IVIG treatment of adenovirus infection-associated macrophage activation syndrome in a two-year-old boy: case report and review of the literature.Sirolimus for the treatment of children with various complicated vascular anomalies.The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis.B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ.Primary immunodeficiency associated with chromosomal aberration - an ESID surveySequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia.The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosisA novel immunodeficiency syndrome associated with partial trisomy 19p13.Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo.Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency.A prospective study on the natural history of patients with profound combined immunodeficiency: An interim analysis.Two newly diagnosed HLA class II-deficient patients identified by rapid vector-based complementation analysis reveal discoordinate invariant chain expression levels.Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders.Amphotericin B transfer to CSF following intravenous administration of liposomal amphotericin B.Unrelated CD3/CD19-depleted peripheral stem cell transplantation for Hurler syndrome.Granulocyte transfusions in children and young adults: does the dose matter?The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency.Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vitro: synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2.Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options - a Retrospective Analysis.Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe.Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease.Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome.Long-term remission after allogeneic hematopoietic stem cell transplantation in LPS-responsive beige-like anchor (LRBA) deficiencyAbnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency.Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome.Vaccination against tick-borne encephalitis virus tests specific IgG production ability in patients under immunoglobulin substitution therapy.Tick-borne encephalitis virus vaccine as additional alternative neoantigen for the clinical immunologist's toolbox.Recessive grey platelet-like syndrome with unaffected erythropoiesis in the absence of the splice isoform GFI1B-p37.Long-term follow up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study.[Adjuvant autologous tumour cell vaccination in patients with renal cell carcinoma. Overall survival analysis with a follow-up period in excess of more than 10 years].Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemiBaby genome screening: paving the way to genetic discrimination?Selective engraftment of donor CD4+25high FOXP3-positive T cells in IPEX syndrome after nonmyeloablative hematopoietic stem cell transplantation.
P50
Q33417357-9BC375FE-A196-423D-AEC2-41ACC8CB924CQ33420073-A7DAEBA4-6939-4ECE-A9DA-5A27A3469746Q33423865-151659CD-A383-4052-B343-41B69917DDCDQ33429970-91087767-00C1-497D-AC37-739D702322D4Q33433162-51538847-D871-47FA-978F-2A6F25A611C3Q33590490-E3D0707F-EE2A-4151-B890-493770539E08Q34473485-7509C635-F505-4876-BD4C-8D5222CD7843Q35590566-56FB02FF-66C8-4095-9111-B0147F9134E4Q35651949-069F3A40-BD42-4705-9345-D3E5FB0C482EQ35800864-D7A1FE31-03AD-4B33-A135-D161EF04B32AQ36779390-CC93948C-B34D-4322-9E2D-931ED06F66B5Q37148529-3AED7E9B-C167-4068-8F7F-DDD18C4A12E7Q37377927-1EEB3849-2330-4AFE-9334-2D303655EAB7Q37623818-5FC30F46-17DA-456D-8D7A-0FF908F2FA3CQ37658726-5C4372E7-04E0-4EA9-AB48-BBED80990352Q38361644-BA3A9765-BDF1-4C1C-9474-B03799D9193EQ38406282-F7E701F0-FFEB-4411-9593-9E4EBF9EFA49Q39361482-9E5D2A3C-B665-4F79-98FF-43E778A9747FQ39733109-53D09691-0DF7-4D60-BBE9-4B46FCCF6CB6Q40137865-98C98D5D-6E6F-4BA9-A45B-4F68923C2425Q40197617-EF6ACD3D-4828-48CA-B60A-BE8904418F9BQ40214372-94450C35-FCAD-4D47-8776-81281BD787B7Q40395707-6E4B568A-9BA1-4A63-A5A3-519D5E1CA44FQ40832724-2934DC9C-F17F-4EFE-9ACE-B8D869510C0CQ41002634-40DCD5E2-904C-4427-AD62-0280FCBEC498Q41053811-6FE74BA8-D2F8-4FF3-8F14-FB0CE5AAD222Q41462651-D93567B2-C90D-4BD9-8BE5-A27147624760Q42265794-934AA214-324A-4FC1-9D59-9168B761C98FQ42325007-6D7B0034-E63A-4015-9CEA-3646AA01BF8CQ42557833-DB2D4EDB-BC68-4154-ACF7-47F68D838622Q42664067-B2EB81BA-9D84-4C90-98B7-C2C0D2615A5CQ42745318-EF1B24EA-8D76-4CCC-B200-6D677D271E50Q42998784-F7EB3BAB-EBB5-4683-810D-43C8291595AFQ44043890-971386A6-01F6-4A40-869C-7272A56F2AD6Q45387284-AAB497F0-98FB-460C-B7B2-8F4B889CB21FQ45875838-4AC67431-0DD8-46EB-BAF8-3F2B5C6A297FQ45948681-6EFBB3DD-EA27-43FC-9876-000F69ECAE37Q46530395-27192D20-5B8A-44DE-80B4-37DA76799E42Q47555725-EEEEAA2B-FAA5-46B1-87E2-206D50706939Q47702499-90D5A2E0-428A-4A65-9C2C-89E217E4F92E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Markus G. Seidel
@ast
Markus G. Seidel
@en
Markus G. Seidel
@es
Markus G. Seidel
@sl
type
label
Markus G. Seidel
@ast
Markus G. Seidel
@en
Markus G. Seidel
@es
Markus G. Seidel
@sl
altLabel
Markus Seidel
@en
prefLabel
Markus G. Seidel
@ast
Markus G. Seidel
@en
Markus G. Seidel
@es
Markus G. Seidel
@sl
P1053
N-9951-2017
P106
P1153
7102273718
P21
P2798
P31
P3829
P3835
markus-g-seidel
P496
0000-0003-0981-8661